Somnigroup Announces Successful Term Loan B Repricing
Werte in diesem Artikel
DALLAS, June 18, 2025 /PRNewswire/ -- Somnigroup International Inc. (NYSE: SGI, "Company" or "Somnigroup") today announced the successful repricing of its $1.6 billion Term Loan B due October 2031.
The loan was repriced with a reduction to the current applicable margin by 25 basis points, from SOFR plus 2.50% to SOFR plus 2.25%, with a further step-down to SOFR plus 2.00% if total net leverage is below 3.0x adjusted EBITDA per the Company's credit agreement ("adjusted EBITDA"). Concurrent with the repricing, the Company intends to prepay $100 million of the outstanding term loan B principal balance with cash on hand and revolver borrowings. The Company estimates the repricing and prepayment will produce annualized cash interest savings of approximately $5 million, with the opportunity to realize further annualized cash interest savings of $4 million if total net leverage is below 3.0 times adjusted EBITDA.
Scott Thompson, Somnigroup Chairman and Chief Executive Officer, commented, "We are very pleased to announce this successful debt repricing, which demonstrates continued lender confidence in Somnigroup and our team's dedication to maintaining a strong financial position. The team is focused on driving our robust free cash flow, reducing our leverage ratio and delivering our shareholders above market returns."
Forward-Looking Statements
This press release contains statements that may be characterized as "forward-looking," within the meaning of the federal securities laws. Such statements might include information concerning one or more of the Company's plans, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words "estimates," "expects," "intends," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to future performance and debt leverage expectations. Any forward-looking statements contained herein are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations, meet its guidance, or that these beliefs will prove correct. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.
About Somnigroup
Somnigroup (NYSE: SGI) is the world's largest bedding company, dedicated to improving people's lives through better sleep. With superior capabilities in design, manufacturing, distribution and retail, we deliver breakthrough sleep solutions and serve the evolving needs of consumers in more than 100 countries worldwide through our fully-owned businesses, Tempur Sealy, Mattress Firm and Dreams. Our portfolio includes the most highly recognized brands in the industry, including Tempur-Pedic®, Sealy®, Stearns & Foster®, and Sleepy's®, and our global omni-channel platform enables us to meet consumers wherever they shop, offering a personal connection and innovation to provide a unique retail experience and tailored solutions.
Somnigroup Investor Relations Contact
Aubrey Moore
Investor Relations
Somnigroup International Inc.
800-805-3635
Investor.relations@somnigroup.com
View original content:https://www.prnewswire.com/news-releases/somnigroup-announces-successful-term-loan-b-repricing-302484374.html
SOURCE Somnigroup International
Übrigens: Tempur Pedic International und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Tempur Pedic International
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Tempur Pedic International
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Tempur Pedic International Inc.
Analysen zu Tempur Pedic International Inc.
Datum | Rating | Analyst | |
---|---|---|---|
28.01.2019 | Tempur Pedic International Overweight | Barclays Capital | |
15.03.2018 | Tempur Pedic International Buy | Stifel, Nicolaus & Co., Inc. | |
07.02.2018 | Tempur Pedic International Outperform | Wedbush Morgan Securities Inc. | |
22.08.2017 | Tempur Pedic International Buy | Stifel, Nicolaus & Co., Inc. | |
18.05.2017 | Tempur Pedic International Neutral | Tigress Financial |
Datum | Rating | Analyst | |
---|---|---|---|
28.01.2019 | Tempur Pedic International Overweight | Barclays Capital | |
15.03.2018 | Tempur Pedic International Buy | Stifel, Nicolaus & Co., Inc. | |
07.02.2018 | Tempur Pedic International Outperform | Wedbush Morgan Securities Inc. | |
22.08.2017 | Tempur Pedic International Buy | Stifel, Nicolaus & Co., Inc. | |
28.09.2016 | Tempur Pedic International Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
18.05.2017 | Tempur Pedic International Neutral | Tigress Financial | |
08.05.2017 | Tempur Pedic International Hold | SunTrust | |
30.01.2017 | Tempur Pedic International Neutral | Instinet | |
24.05.2016 | Tempur Pedic International Hold | Topeka Capital Markets | |
22.04.2016 | Tempur Pedic International Neutral | Wedbush Morgan Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
10.02.2017 | Tempur Pedic International Sell | UBS AG | |
30.01.2017 | Tempur Pedic International Sell | SunTrust |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tempur Pedic International Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen